DEXCOM INC is 1.2x more valuable than WEST PHARMACEUTICAL SERVICES INC by market capitalization ($28.85 B vs $23.38 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | WST | DXCM |
|---|---|---|
| Market cap | $23.38 B | $28.85 B |
| US-listed rank | #553 | #473 |
| Revenue (latest FY) | $3.07B | $4.66B |
| Net income (latest FY) | $493.70M | $836.30M |
| Net margin | 16.1% | 17.9% |
| P/E (trailing FY) | 47.4 | 34.5 |
| SEC filings | 3,429 | 2,566 |
DEXCOM INC is 1.2x more valuable than WEST PHARMACEUTICAL SERVICES INC by market capitalization ($28.85 B vs $23.38 B).
In their latest fiscal years, WEST PHARMACEUTICAL SERVICES INC reported $3.07B in revenue while DEXCOM INC reported $4.66B.
Full pages: WEST PHARMACEUTICAL SERVICES INC and DEXCOM INC, or browse the full rankings.